Exploring the impact of the liver-intestine-brain axis on brain function in non-alcoholic fatty liver disease

Exploring the impact of the liver-intestine-brain axis on brain function in non-alcoholic fatty liver disease

This study investigates the molecular complexities of non-alcoholic fatty liver disease (NAFLD)-induced brain dysfunction, with a focus on the liver-intestine-brain axis and potential therapeutic interventions. The main objectives include understanding critical microbiota shifts in NAFLD, exploring...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jingting Zhang, Keyan Chen, Fu Chen
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Journal of Pharmaceutical Analysis
Subjects:	Non-alcoholic fatty liver disease Liver-intestine-brain axis Microbiota shifts Deoxycholic acid Microglial cells JAK2/STAT3 signaling
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095177924001746
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease
by: T. S. Krolevets, et al.
Published: (2020-12-01)

Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

Features of the State of Internal Organs and the Structure of Comorbidity in Deceased Persons With Alcoholic Liver Cirrhosis, Non-alcoholic Fatty Liver Disease at the Cirrhosis Stage and Alcoholic Liver Cirrhosis Associated With Insulin Resistance and Obesity
by: N. Matkovska
Published: (2020-06-01)

Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
by: Zhiqing Zhang, et al.
Published: (2025-06-01)

Curcumin and non-alcoholic fatty liver disease
by: Nasrin Sharifi, et al.
Published: (2024-06-01)

Deciphering the role of dietary modifications and gut dysbiosis in Non-Alcoholic Fatty Liver Disease
by: Meenakshi Vachher, et al.
Published: (2025-06-01)

Non-Alcoholic Fatty Liver Disease and the Risk of Liver Fibrosis in Chronic Hepatitis B Patients
by: Andri Sanityoso Sulaiman, et al.
Published: (2023-09-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Research Progress in Microbe-Gut-Liver Axis and Alcoholic Liver Disease and Nutritional Interventions for It
by: ZHENG Hongxing, JI Le, QI Shanshan
Published: (2024-10-01)

Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)

Sex-specific effect of dietary fatty acids on non-alcoholic fatty liver disease
by: Jianhua Chen, et al.
Published: (2025-07-01)

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)

Evolving ideas on non-alcoholic fatty liver disease: from risk to catastrophe
by: Yu. M. Stepanov, et al.
Published: (2020-04-01)

Normative Modeling Reveals Age‐Atypical Cortical Thickness Differences Between Hepatic Steatosis and Fibrosis in Non‐Alcoholic Fatty Liver Disease
by: Minchul Kim, et al.
Published: (2025-04-01)

Assessment of the Functional Status of the Small Intestine in Patients with Non-Alcoholic Fatty Liver Disease
by: Ya. M. Vakhrushev, et al.
Published: (2020-12-01)

Clinical Significance of Serum Bile Acid Profiles in Fatty Liver
by: Sun HY, et al.
Published: (2024-12-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Editorial: The gut-liver axis: the main role of microbiome in liver diseases
by: Giovanni Tarantino, et al.
Published: (2025-03-01)

Gegen-Sangshen oral liquid and its active fractions mitigate alcoholic liver disease in mice through repairing intestinal epithelial injury and regulating gut microbiota
by: Shulin Wei, et al.
Published: (2024-12-01)

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy
by: Siwen Shen, et al.
Published: (2025-07-01)

Intestinal microbiota in obese children with non-alcoholic fatty liver disease depending on the gallbladder function
by: Yu. M. Stepanov, et al.
Published: (2022-05-01)

Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease
by: Youwen Tan, et al.
Published: (2024-12-01)

Serum β-klotho is a potential biomarker for diagnosing alcoholic liver disease and differentiating from nonalcoholic fatty liver disease
by: Chengmei Fang, et al.
Published: (2025-08-01)

Profile of Children With Non-alcoholic Fatty Liver Disease Referred to a Hospital in Iran
by: Amin Ghanbari, et al.
Published: (2024-12-01)

Correction of liver changes caused by alcohol rates with probiotics
by: Zhadyra Orynbayeva, et al.
Published: (2024-10-01)

Liver-specific expression of ANGPTL8 promotes Alzheimer’s disease progression through activating microglial pyroptosis
by: Jiarui Wei, et al.
Published: (2025-07-01)

The prevalence of metabolic syndrome in patients with non-alcoholic fatty liver disease in Erbil city
by: Maryam Abdulwahid, et al.
Published: (2024-12-01)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)

Prevalence of non-alcoholic fatty liver disease among the working-age population: associations with socio-demographic indicators and behavioral risk factors (ESSE RF-2 data)
by: S. E. Evstifeeva, et al.
Published: (2022-10-01)

Diagnostic and pathogenetic significance of apolipoprotein disorders in patients with alcoholic fatty liver
by: Mladenović Bojan, et al.
Published: (2017-01-01)

Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia
by: Masahiro Kikuchi, et al.
Published: (2024-09-01)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
by: Evgenia Pavlovna Kosobyan, et al.
Published: (2010-03-01)

NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE
by: O. M. Drapkina, et al.
Published: (2017-11-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Chronic alcohol intake disrupts cytochrome P450 enzyme activity in alcoholic fatty liver disease: insights into metabolic alterations and therapeutic targets
by: Qian Zhu, et al.
Published: (2025-05-01)

Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease
by: Wei Li, et al.
Published: (2024-12-01)

Body Composition and Progression of Biopsy‐Proven Non‐Alcoholic Fatty Liver Disease in Patients With Obesity
by: Qianyi Wan, et al.
Published: (2024-12-01)

The effect of non-alcoholic fatty liver disease on the development of cardiovascular diseases
by: N. A. Starodubtseva, et al.
Published: (2025-03-01)